In patients with nondiabetic glomerular disorders, more research is needed to examine SGLT2 expression and its impact on mesangial cells and podocytes to accurately evaluate how SGLT2is affect hematuria in glomerulonephritis patients. The gene discussed is SLC5A2; the disease is glomerular disorder.